B2DB — Who said what, where, and when

Stephanie Annett

Senior Lecturer and Principle Investigator, RCSI

Imuphile Therapeutics is a university pre–spin out and a developing a preclinical first in class RNA based therapeutic that promotes weight loss by increasing energy expenditure, targeting obesity and related metabolic disorders.

Events Stephanie Annett has spoken at